Dietary therapy ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	3

96. クローン病

---

臨床試験数 : 2,442 /  薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03266484 (ClinicalTrials.gov)	November 13, 2017	25/8/2017	Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease	Effect of Dietary Therapy With a Probiotic Mixture on the Gut Microbiome and Fatigue Symptoms in Patients With Quiescent Inflammatory Bowel Disease - A Clinical Trial	Inflammatory Bowel Diseases;Crohn Disease;Ulcerative Colitis	Dietary Supplement: Probiotic Mixture;Dietary Supplement: Placebo	Massachusetts General Hospital	Winclove Bio Industries BV	Active, not recruiting	18 Years	75 Years	All	100	N/A	United States
2	NCT02231814 (ClinicalTrials.gov)	December 2016	27/8/2014	The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease	Dietary Therapy Using the Crohn's Disease Exclusion Diet (CDED) With Partial Enteral Nutrition or Alone for Induction and Maintenance of Remission in in Adults With Mild to Moderate Crohn's Disease- A Pilot Study	Crohn's Disease	Dietary Supplement: Crohns Disease Exclusion Diet + PEN;Other: Crohns Disease Exclusion Diet	Prof. Arie Levine	NULL	Completed	18 Years	55 Years	All	40	N/A	Israel
3	NCT00343642 (ClinicalTrials.gov)	September 2006	21/6/2006	Dietary Treatment of Crohn's Disease	Dietary Treatment of Crohn's Disease	Crohn's Disease;Inflammatory Bowel Disease	Dietary Supplement: Time and attention + fructo-oligosaccharide placebo;Dietary Supplement: dietary therapy + fructo-oligosaccharide placebo;Drug: Time and attention + active fructooligosaccharide supplementation	Rush University Medical Center	National Center for Complementary and Integrative Health (NCCIH)	Completed	18 Years	80 Years	Both	73	Phase 1/Phase 2	United States